1.
Eosinophilic granulomatosis with polyangiitis: sequential use of mepolizumab following rituximab for inadequate asthma control despite vasculitis remission. Reumatismo [Internet]. 2023 Dec. 19 [cited 2025 Jun. 11];75(4). Available from: https://www.reumatismo.org/reuma/article/view/1588